Fifth Third Bancorp’s Oncolytics Biotech ONCY Stock Holding History

Fifth Third Bancorp’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43.2K	Buy	+45,526	New	+$42.2K	﹤0.01%	3281
2022 Q3	–	Sell	-1,000	Closed	-$1K	–	2718
2022 Q2	$1K	Sell	1,000 -10,000	-91%	-$12.2K	﹤0.01%	2558
2022 Q1	$17K	Buy	11,000 +10,000	+1,000%	+$16.8K	﹤0.01%	1879
2021 Q4	$1K	Hold	1,000	–	–	﹤0.01%	2627
2021 Q3	$2K	Hold	1,000	–	–	﹤0.01%	2482
2021 Q2	$3K	Hold	1,000	–	–	﹤0.01%	2300
2021 Q1	$4K	Hold	1,000	–	–	﹤0.01%	2228
2020 Q4	$2K	Hold	1,000	–	–	﹤0.01%	2236
2020 Q3	$2K	Hold	1,000	–	–	﹤0.01%	2064
2020 Q2	$2K	Hold	1,000	–	–	﹤0.01%	1981
2020 Q1	$1K	Buy	+1,000	New	+$2.5K	﹤0.01%	2058

Other funds holding ONCY

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

Fifth Third Bancorp's ONCY Position: Q2 2026 in Review

Fifth Third Bancorp opened a new position in Oncolytics Biotech (ONCY) in Q2 2026: 45,526 shares worth $43.2K. The stake represents ﹤0.01% of the portfolio and ranks #3281 among its holdings. This is a return to the name: Fifth Third Bancorp previously reported a position in ONCY as recently as Q2 2022.

Fifth Third Bancorp first reported a position in ONCY in Q1 2020 and has held it in 11 quarters since. 75 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

Fifth Third Bancorp held 45,526 shares of Oncolytics Biotech worth $43.2K as of Q2 2026.
Oncolytics Biotech was a new Fifth Third Bancorp position in Q2 2026.
Oncolytics Biotech made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3281 holding.
Fifth Third Bancorp first reported a position in Oncolytics Biotech in Q1 2020 and has held it in 11 quarters since.
75 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.